Replies to post #51097 on Cytogenix (fka CYGX)

[arnold]

Wawh, Your comments about past PR's is the result of PR's that are all fluff with no real information and no follow up. You asked about financing . Here is a PR about Financing that is a good example .

CytoGenix Engages Jesup & Lamont as Financial Advisor and Placement Agent
Houston, TX, (June 29, 2004) Cytogenix, Inc. (OTCBB: CYGX)

CytoGenix, Inc. (OTCBB: CYGX) announced today that it has engaged the services of Jesup & Lamont Securities Corp., New York, New York, as exclusive financial advisor and placement agent for the purpose of raising equity capital to support the Company's on-going product development efforts.

CytoGenix is conducting pre-clinical product development studies preliminary to filing for Investigational New Drug Applications before the Food and Drug Administration for the Company's lead compounds against bacterial infections, sepsis and herpes.

The Company also expects to use a portion of funds to build a DNA manufacturing facility. Frank Vazquez, Chief Operations Officer of CytoGenix explained, "As we approach clinical trials for our products, our need for clinical grade DNA will expand. It will be more cost effective for us to produce the necessary quantities ourselves rather than purchase needed supplies in the market. We also expect to utilize excess capacity to service the growing DNA market."

Malcolm Skolnick, President and CEO of CytoGenix stated, "We are pleased that our Company's progress has enabled us to secure the assistance of an investment banking firm with Jesup & Lamont's experience and expertise. These funds will be used to accelerate product development and clinical trials required by the FDA so that we may market our DNA therapeutic compounds."

Established in 1877 and headquartered in New York City, Jesup & Lamont is a full service brokerage and investment banking firm providing institutional sales and trading services, equity research, and financial advisory services in connection with a broad range of corporate finance matters.

CytoGenix, Inc. is a biopharmaceutical company that develops and markets innovative products and services based on its proprietary DNA expression technology. CytoGenix has products in pre-clinical development including, anti-herpes, anti-psoriasis and anti-inflammatory topical creams. The company owns a US patent for its core DNA expression technology and has 40 international or US pending patent applications.

SAFE HARBOR: Except for statements of historical fact, the statements in this press release are forward-looking. Such statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include, but are not limited to, general economic conditions, risks associated with the acceptance of new products, competition, and other factors more fully detailed in the company's filings with the Securities and Exchange Commission. Additional information about CytoGenix and its technology can be found on the website at www.cytogenix.com.

[frog585]

The Wawh...Would you consider just a numerical evaluation of 1 to 10...10 being "very confident" of the overall success of cygx. I am a very long, long who has posted perhaps four times in five years BUT would sure appreciate any reasonable persons feedback from the SHM....Thanks if you respond...frog

[gdepc]

Wawh

I got the same response from attendees of the SHM

Why bother posting to add fuel for the negative spin bunch.

I think we all see how far off topic they are now anyway.

The sick part is half of them are shareless
gdepc

[Kancamangus]

I respect your opinion, Wawh.

But I disagree.

I think you may be inverting your causality here. If I post something "negative" here, the only reason it carries any weight is because the company's performance under existing management supports any assertions I make.

Look, I've heard good rumors, too. Really good ones. You know what the problem with them has been? They simply have failed to come to fruition. Without exception. Not a single one of them.

Now that's rumors for you. Nobody can blame anybody but themselves for believing rumors, and I don't let myself off that hook. It's my fault if I make unwise financial decisions based on rumors, and I have no problem admitting here that I've done it because reinforcing that honesty through public admission helps me to avoid those mistakes in the future.

But this situation is a bit worse than that. CYGX has its own CEO publicly failing to follow through on things he has explicitly said he would do. Repeatedly.

In other words, I can appreciate your disgust with the situation, but if you choose to blame iHub posters with dragging down the company, I would invite you to consider this:

If what you're asserting is the truth, it means that iHub posters who regularly pan the company's performance have more credibility in the open market than the CYGX management whose responsibilities include both the company's performance and stock price.

This isn't sophistry. It isn't trickery. This is logic. Cause and effect.

Ask yourself: if what you're saying is true, why are YOU invested here?

That's the question I ultimately asked myself, and the answer I grudgingly gave (at the cost of many 10's of thousands of dollars) was that there was no reason to stay on other than the rumors and rickety assurances of an executive management staff that had utterly failed to deliver on one promise in recent memory.

It's why I decided to get out, and it isn't exactly irony that the money I pulled out of CYGX has increased by just under 5% in the couple of weeks that have elapsed since I bailed.

Is CYGX a "bad" investment?

Irrelevant question.

The real question (as far as I'm concerned) would be to ask if there's any legitimate and concrete means of determining what kind of investment, whether good or bad, it is at all.

Numbers? None.

Track-record? None.

Assets? None.

Industry Experience? None.

Products? One.

Customers? Only one alleged re-order.

Patents? One.

Outstanding Shares? 150M.

Stock Price? $0.39

Cash? < $1M

Required Cash? > $15M

I don't need to bash this company. It's doing a splendid job of imploding on itself.

You'll see me as a shareholder again when the guy responsible for that scoreboard has left his post.

[BigB]

here here!!!!!!!!!

or is

hear hear?

[junkmasterg]

negative posts on iHub has made many investors doubtful

if you make any kind of investment decision based on anything you read on message boards, then IMO you have no business investing in the first place

that's the bottomline...

as for your suggestion for a different "tone".... well that gives me the creeps

as long as everyone remains civil to each other, then ALL opinions are encouraged pro or con.

It's up to you to decide what post has information that you can use (if any). You can filter info anyway you like here

[downregul8]

Wawh – It’s unfortunate if anyone feels concerned about posting substantive information for fear of adding fuel to the fire. Information is what allows people to make “informed” decisions. In fact it’s the lack of information that leads to doubt so not posting information is likely to contribute to the doubt than actual updates – good or bad. Plus, the lack of information, when some was anticipated, could also lead the already disenchanted people to conclude that there was nothing good to report from the meeting. I can’t say that anything posted won’t be dissected but I will say that proof of real progress would not be trashed. New promises – maybe – but only because of the company’s track record. The board is refection of the company’s actions – not the other way around.

It’s each participants choice to share or not and I still hope some additional SHM reports come forward. The board is what we all choose to make it – and for the most part it's been exceptional.